Botulinum toxin type A
A double-blind, placebo-controlled trial in 264 participants supports the studied botulinum toxin A product for glabellar lines. Results do not automatically apply to every brand, dose or facial area.
Scientific References (1)
- Carruthers JA, Lowe NJ, Menter MA et al.. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. · J Am Acad Dermatol (2002)PMID 12063480DOI